Ensign Peak Advisors, Inc Tg Therapeutics, Inc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 328,992 shares of TGTX stock, worth $12.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
328,992
Previous 456,017
27.86%
Holding current value
$12.1 Million
Previous $13.7 Million
5.49%
% of portfolio
0.03%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$580 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$418 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$128 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$112 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.33B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...